ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。

CALT Calliditas Therapeutics AB

20.13
0.00 (0.00%)
プレマーケット
最終更新日: 20:34:58
15分遅延
名称 銘柄コード 市場 種別
Calliditas Therapeutics AB CALT NASDAQ Depository Receipt
  前日比 前日比 % 現在値 時刻
0.00 0.00% 20.13 20:34:58
始値 安値 高値 終値 前日終値
20.13
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0615:16PRNUSCalliditas announces positive topline results of Phase 2..
2024/5/0615:11PRNUSCalliditas announces positive topline results of Phase 2..
2024/4/2502:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
2024/4/2502:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
2024/4/2416:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
2024/4/2416:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
2024/4/1820:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
2024/4/1820:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
2024/4/0920:24PRNUSCalliditas Therapeutics to Attend Conferences in April
2024/4/0920:22PRNUSCalliditas Therapeutics to Attend Conferences in April
2024/4/0821:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
2024/4/0821:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
2024/4/0816:24PRNUSCalliditas receives notice of allowance for United States..
2024/4/0816:22PRNUSCalliditas receives notice of allowance for United States..
2024/3/1210:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
2024/3/0616:38PRNUSCalliditas announces an additional seven year orphan drug..
2024/3/0616:34PRNUSCalliditas announces an additional seven year orphan drug..
2024/3/0121:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
2024/3/0121:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
2024/2/2115:45PRNUSCalliditas Year-end report, January - December 2023
2024/2/2115:43PRNUSCalliditas Year-end report, January - December 2023
2024/2/1415:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
2024/2/1415:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
2024/2/1401:28PRNUSCalliditas provides patent update
2024/2/1401:26PRNUSCalliditas provides patent update
2024/1/0822:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2024/1/0816:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
2024/1/0816:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
2024/1/0801:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
2024/1/0801:19PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
2024/1/0801:07PRNUSCalliditas to present at JP Morgan Healthcare Conference
2024/1/0801:05PRNUSCalliditas to present at JP Morgan Healthcare Conference
2023/12/2806:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2802:22PRNUSCalliditas refinances existing term loan with Euro 92..
2023/12/2802:16PRNUSCalliditas refinances existing term loan with Euro 92..
2023/12/2109:00DJNStocks to Watch: Micron, Warner Bros. Discovery, Paramount..
2023/12/2107:33DJNCalliditas Therapeutics Shares Rise 33% After FDA Approves..
2023/12/2107:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2023/12/2106:34PRNUSCalliditas Therapeutics announces full FDA approval of..
2023/12/2106:33PRNUSCalliditas Therapeutics announces full FDA approval of..
2023/12/1123:40PRNUSCalliditas Receives Notice of Allowance for United States..
2023/12/1123:38PRNUSCalliditas Receives Notice of Allowance for United States..
2023/12/0117:27PRNUSCalliditas announces additions to the management team
2023/12/0117:21PRNUSCalliditas announces additions to the management team
2023/11/3016:55PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
2023/11/3016:49PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
2023/11/2417:13PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
2023/11/2417:10PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
2023/11/0800:31PRNUSCalliditas to present at upcoming investor conferences
2023/11/0800:29PRNUSCalliditas to present at upcoming investor conferences

最近閲覧した銘柄

Delayed Upgrade Clock